PRQR
PRQR
NASDAQ · Biotechnology

Proqr Therapeutics Nv

$1.50
+0.04 (+2.74%)
As of Feb 8, 2:07 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 53.23M 53.79M 56.60M
Net Income 2.83M 2.31M 2.33M
EPS
Profit Margin 5.3% 4.3% 4.1%
Rev Growth +4.7% +4.8% +15.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 16.45M 17.98M 18.29M
Total Equity 105.65M 107.54M 109.94M
D/E Ratio 0.16 0.17 0.17
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 4.51M 4.13M 4.65M
Free Cash Flow 2.47M 1.88M 2.75M